FDA.reportPublic FDA data

lutetium Lu 177 vipivotide tetraxetan 1000 MBq/mL Injection

RxCUI
2597057
RxNorm name
lutetium Lu 177 vipivotide tetraxetan 1000 MBq/mL Injection
Display name
lutetium Lu 177 vipivotide tetraxetan 1000 MBq/mL Injection
Full name
lutetium Lu 177 vipivotide tetraxetan 1000 MBq/mL Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PLUVICTOLUTETIUM LU 177 VIPIVOTIDE TETRAXETANNovartis Pharmaceuticals Corporation14908037-2892-4d98-a053-253ce35afb1a2026-08-12Warnings, Adverse reactionsExact identifier
rxcui: 2597057

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
14908037-2892-4d98-a053-253ce35afb1alutetium Lu 177 vipivotide tetraxetan 1000 MBq/mL Injection [PSN] · 12.5 ML lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML Injection [SCD] · lutetium Lu 177 vipivotide tetraxetan 200 mCi per 12.5 ML Injection [SY] · lutetium Lu 177 vipivotide tetraxetan 7.4 GBq per 12.5 ML Injection [SY]43These highlights do not include all the information needed to use PLUVICTO safely and effectively. See full prescribing information for PLUVICTO. PLUVICTO ® (lutetium Lu 177 vipivotide tetraxetan) injection, for intravenous use Initial U.S. Approval: 202220260407